Qube Research & Technologies (QRT)
XBIT icon

Qube Research & Technologies (QRT)’s XBiotech XBIT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.2K Buy
33,570
+14,879
+80% +$36K ﹤0.01% 3053
2026
Q1 		$43.9K Sell
18,691
-1,920
-9% -$4.64K ﹤0.01% 3197
2025
Q4 		$49.3K Sell
20,611
-9,706
-32% -$23.9K ﹤0.01% 3287
2025
Q3 		$80.6K Sell
30,317
-1,901
-6% -$5.63K ﹤0.01% 3104
2025
Q2 		$95.7K Buy
+32,218
New +$93.7K ﹤0.01% 3046
2024
Q3 		– Sell
-12,917
Closed -$66.4K – 4215
2024
Q2 		$66.4K Sell
12,917
-54,745
-81% -$422K ﹤0.01% 2682
2024
Q1 		$550K Buy
67,662
+11,185
+20% +$64.1K ﹤0.01% 2494
2023
Q4 		$226K Buy
56,477
+53,917
+2,106% +$215K ﹤0.01% 2727
2023
Q3 		$10.5K Buy
+2,560
New +$12.8K ﹤0.01% 3300
2022
Q4 		– Sell
-12,591
Closed -$46K – 3061
2022
Q3 		$46K Sell
12,591
-1,798
-12% -$8.46K ﹤0.01% 2155
2022
Q2 		$81K Buy
+14,389
New +$96.8K ﹤0.01% 2015

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Qube Research & Technologies (QRT)'s XBIT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its XBiotech (XBIT) stake by 80% in Q2 2026, buying an estimated $36K and bringing the position to 33,570 shares worth $77.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3053.

Qube Research & Technologies (QRT) first reported a position in XBIT in Q2 2022 and has held it in 11 quarters since. The position peaked at $550K in Q1 2024. 36 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • Qube Research & Technologies (QRT) held 33,570 shares of XBiotech worth $77.2K as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 14,879 XBiotech shares in Q2 2026, an estimated $36K.
  • XBiotech made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3053 holding.
  • Qube Research & Technologies (QRT) first reported a position in XBiotech in Q2 2022 and has held it in 11 quarters since.
  • Qube Research & Technologies (QRT)'s XBiotech position peaked at $550K in Q1 2024.
  • 36 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.